Esmée C A van der Sar

6PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Radiation therapyVeterinary diagnosis and diagnosticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.

|Apr 24, 2023
Impact of uptake time on image quality of [68 Ga]Ga-PSMA-11 PET/CT.

Esmée C A van der Sar, Sebastiaan L Meyer Viol, Arthur J A T Braat

|Mar 24, 2023
Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).

Esmée C A van der Sar, Arthur J A T Braat, Jochem R N van der Voort-van Zyp

|Aug 13, 2022
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging.

Esmée C A van der Sar, Willem R Keusters, Ludwike W M van Kalmthout

|Jul 27, 2022
Baseline Imaging Derived Predictive Factors of Response Following [177Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis.

Esmée C A van der Sar, Adinda J S Kühr, Sander C Ebbers

|Jun 02, 2021
Competition ('Steal' Phenomenon) between [68Ga]Ga-PSMA-11 Uptake in Prostate Tumor Tissue Versus Healthy Tissue.

Esmée C A van der Sar, Bart de Keizer, Marnix G E H Lam

Pageof 1

Frequent Collaborators

4 joint publications

Arthur J A T Braat

3 joint publications

Bart de Keizer

1 joint publications

Sander C Ebbers

1 joint publications

Andrew M Henderson